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Abstract
Background: Diabetes is mostly assessed by the fasting glucose level. Several studies reported that serum fasting
glucose levels and cardiovascular disease are associated with MC4R.
Methods: A total of 4294 subjects participated in this study. There were 1810 subjects with cardiovascular disease
among the 4294 subjects. We used multivariate linear regression models and multiple logistic regression analysis.
Results: Individuals with the TC/CC genotype had a 1.29-fold higher risk of diabetes than did those with the TT
genotype when adjusting for age, sex, and BMI (OR, 1.29; 95% CI, 1.04–1.60). For healthy subjects, the association
was significant in women (OR, 1.99; 95% CI, 1.01–3.93). Men with the TC/CC genotype had a 1.21-fold higher risk of
cardiovascular disease than did those with the TT genotype when adjusting for age, sex, and BMI (OR, 1.21; 95% CI,
1.04–1.41). The relationship between MC4R and cardiovascular disease was stronger in lean men (OR, 1.40; 95% CI,
1.12–1.74, p = 0.0028) than in overweight men.
Conclusions: This study suggests that the rs17782313 SNP in MC4R is related to diabetes and the SNP is also
associated with cardiovascular disease in lean men.
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Background
Diabetes is mainly assessed by the fasting blood-glucose
level [1]. Several previous studies reported that the
melanocortin-4 receptor (MC4R) (MIM 155541) gene is
a candidate as a causal gene for type 2 diabetes [2, 3].
MC4R deficiency is related to monogenic obesity [4].
The MC4R rs17782313 SNP has also been linked with
obesity in Europeans and Koreans [5, 6]. The SNP
rs17782313 was also associated with diabetes in several
studies [3, 7, 8]. In Korea, obesity increases the risk of
death from cardiovascular disease [9].
Recent studies have reported that the MC4R gene was
related to cardiovascular disease [10, 11]. In this study,
we investigated the relationship between diabetes,
cardiovascular disease, and the rs17782313 MC4R SNP
in Korean men and women. We also evaluated modifica-




A total of 4294 subjects were the participants who had
general health examinations in Health Promotion Center
in University hospitals [12]. The biological samples for
DNA extraction were obtained prospectively between
2004 and 2013 as a part of the Korean Cancer Preven-
tion Study-II (KCPS-II) Biobank [13]. There were 1810
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subjects with Cardiovascular Disease (CVD) among the
4294 subjects. The cases were obtained by the NHIC
health-insurance reimbursement data. The codes of the
International classification of Disease (ICD), 10th Revision
(I00-I99), were used for the definition of CVD. Because of
missing fasting blood-glucose level, body mass index
(BMI), and SNP rs17782313 data, 35 subjects were ex-
cluded. Therefore, the final subjects included 4259 people,
and 1782 subjects among them were Cardiovascular
Disease (CVD) patients. Among 1782 Cardiovascular
Disease (CVD) patients, 1409 individuals had ischemic
heart disease and 868 had stroke. The other 2477 subjects
were the healthy subjects. The healthy subjects were
defined as subjects who do not have the cardiovascular
disease.
Data collection
Each participant was interviewed using a structured
questionnaire to collect their personal history of smok-
ing status (never smoked, ex-smoker or current smoker)
and demographic characteristics (age, sex, etc.), and
other characteristics such as medical history and any
medications. Participants were defined as ‘current
smokers’ if they were smoking currently, ‘never smokers’
if they had no prior history of smoking and ‘ex-smokers’
if they had previously smoked but at the time of meas-
urement did not smoke. The weight and height were
measured with participants lightly clothed.
Peripheral venous-blood samples taken after a 12-h
fast and stored at − 70 °C were used for the measure of
fasting blood sugar (FBS), total cholesterol, triglycerides,
and HDL-C. We used a Hitachi-7600 analyzer (Hitachi,
Ltd., Tokyo, Japan) for the clinical chemistry assays. De-
tailed phenotype data were previously described [12, 13].
Genotyping assays
The TaqMan reaction was used for the genotyping of
the rs17782313 MC4R gene SNP [14]. Only the SNPs
with a concordance rate > 99% in duplicates and a geno-
type success rate > 98% were included.
Statistical analysis
Data are shown as means ± standard deviation. PLINK
and SAS ver. 9.4 (SAS Institute, Cary, NC, USA) were
used for most statistical analyses. The linear regression
under the additive genetic model was used to assess the
association of MC4R rs17782313 with fasting blood glu-
cose levels considering age and sex as covariates. We
also used multiple logistic regression analysis under the
recessive model to examine the association of the MC4R
rs17782313 with diabetes and cardiovascular disease.
Body mass index was divided by the median values. The
association between the MC4R SNP, diabetes, and
cardiovascular diseases were expressed by Odds ratios
(ORs) with 95% confidence intervals (CIs). Diabetes was
defined as fasting serum glucose ≥126mg/dL or medica-
tion. All statistical tests were two-sided, and p < 0.05 was
used for the statistical significance.
Results
The mean age in men and in women was 51.9 and 52.7
(Table 1). Diabetes patients were about 8.9% of the sub-
jects; 37.3% in men and 3.9% in women were current
smokers of the sample dataset. Cardiovascular disease
patients were 44.7% of men and 35.9% of women. Table 2
shows the p values from a linear regression model for
FBS levels when age and sex were included as covariates.
The rs17782313 SNP in the MC4R gene was related to
mean FBS level and BMI (effect per allele, 1.542 mg/dL,
p = 0.0057, and 0.227 mg/dL, p = 0.0018). For healthy in-
dividuals, the rs17782313 SNP in the MC4R gene was
related to mean FBS level and BMI (effect per allele,
1.477 mg/dL, p = 0.0205, and 0.237 mg/dL, p = 0.0096).
The relationship between diabetes and the MC4R gene
SNP rs17782313 was examined (Table 3). Individuals
with the TC/CC genotype had a 1.29-fold higher risk of
diabetes than did those with the TT genotype when
adjusting for age, sex, and BMI (OR, 1.29; 95% CI, 1.04–
1.60). When analyzed by sex, the relationship between
MC4R and diabetes was significant only for men (OR,
1.33; 95% CI, 1.04–1.70), not women (OR, 1.10; 95% CI,
0.70–1.75). For healthy subjects, individuals with the
TC/CC genotype had a 1.40-fold higher risk of diabetes
than did those with the TT genotype when for adjusting
age, sex, and BMI (OR, 1.40; 95% CI, 1.01–1.95).
Table 1 General characteristics of the study population
Subjects All Men Women
N 4259 2896 1363
Mean ± SD Mean ± SD Mean ± SD
Age, year 52.2 ± 10.2 51.9 ± 10.3 52.7 ± 10.1
Weight, kg 67.4 ± 11.1 71.8 ± 9.6 58.1 ± 7.7
Body mass index, kg/m2 24.4 ± 3.0 24.8 ± 2.7 23.5 ± 3.2
Fasting blood sugar,
mg/Dl
97.0 ± 22.6 98.8 ± 24.0 93.1 ± 18.7
Systolic blood pressure,
mmHg
121.9 ± 14.5 123.3 ± 13.9 118.9 ± 15.3
Diastolic blood pressure,
mmHg
78.2 ± 10.8 79.7 ± 10.6 75.0 ± 10.5
% % %
Smoking status Ex 28.4 40.1 2.4
Current 26.9 37.3 3.9
Cardiovascular disease 41.8 44.7 35.9
Diabetesa 8.9 10.2 6.2
Family history of diabetes 14.5 14.1 15.4
SD standard deviation
a Diabetes was defined as fasting serum glucose ≥126mg/dL or medication
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However, the association was stronger in women (OR,
1.99; 95% CI, 1.01–3.93), and the association of MC4R
with diabetes was not found in men (OR, 1.24; 95% CI,
0.85–1.81).
The relationship of the MC4R gene SNP rs17782313
to cardiovascular disease was also examined (Table 4).
Men with the TC/CC genotype had a 1.21-fold (range,
1.04–1.41-fold) higher risk of cardiovascular disease than
did those with the TT genotype when for adjusting age,
sex, BMI (OR, 1.21; 95% CI, 1.04–1.41). In contrast, the
relationship of MC4R with cardiovascular disease was
not found in women.
Table 2 Association between the rs17782313 single nucleotide polymorphism in the MC4R gene and fasting blood-sugar levels
based on a linear regression model
Genotypes
Phenotypes TT TC CC Effect
(mg/dL)
P-value
Mean ± SD Mean ± SD Mean ± SD
All subjects (N = 2428) (N = 1578) (N = 253)
Fasting blood sugar, mg/dL 96.0 ± 21.3 98.6 ± 24.9 96.5 ± 18.4 1.542 0.0057*
Body mass index, kg/m2 24.3 ± 2.9 24.5 ± 3.0 24.8 ± 3.2 0.227 0.0018*
Weight, kg 67.2 ± 11.0 67.6 ± 11.1 68.6 ± 11.1 0.739 0.0010*
Systolic blood pressure, mmHg 121.7 ± 14.6 122.0 ± 14.3 122.7 ± 15.0 0.452 0.2032
Diastolic blood pressure, mmHg 78.2 ± 11.0 78.2 ± 10.4 78.4 ± 11.2 0.061 0.8184
% % %
Cardiovascular disease 40.7 44.1 38.3 0.0543
Diabetes 8.0 10.5 7.1 0.0153
Healthy subjects (N = 1439) (N = 882) (N = 156)
Fasting blood sugar, mg/dL 93.6 ± 18.5 96.3 ± 22.5 93.7 ± 13.3 1.477 0.0205*
Body mass index, kg/m2 24.0 ± 2.9 24.2 ± 3.0 24.3 ± 2.6 0.237 0.0096*
Weight, kg 66.5 ± 11.2 66.9 ± 11.5 67.8 ± 10.6 0.839 0.0035*
Systolic blood pressure, mmHg 119.4 ± 13.5 119.3 ± 13.3 119.8 ± 12.1 0.156 0.7119
Diastolic blood pressure, mmHg 78.8 ± 10.9 78.5 ± 10.5 78.8 ± 10.1 −0.039 0.9068
% % %
Diabetes 5.7 8.1 5.1 0.0642
Estimated effect size (β) and p values in the multiple linear regression model considered age and sex in the additive model. P values for cardiovascular
disease and diabetes were obtained from chi-square test. * significant of p < 0.05
Table 3 Odds ratios (OR) of the polymorphic rs17782313 MC4R genotypes for diabetes in the population
Normal Diabetes b
Model 1 Model 2
Subjects Genotype N (%) N (%) OR (95% CIa) P-value OR (95% CIb) P-value
All TT 2233 (57.6) 195 (51.5) 1.00 (reference) 1.00 (reference)
(n = 4259) TC /CC 1647 (42.4) 184 (48.6) 1.32 (1.07–1.64)* 0.0113 1.29 (1.04–1.60) * 0.0218
Men TT 1513 (58.2) 151 (51.4) 1.00 (reference) 1.00 (reference)
TC/ CC 1089 (41.8) 143 (48.6) 1.34 (1.05–1.72) * 0.0182 1.33 (1.04–1.70) * 0.0219
Women TT 720 (56.3) 44 (51.8) 1.00 (reference) 1.00 (reference)
TC/ CC 558 (43.7) 41 (48.2) 1.25 (0.80–1.96) 0.3337 1.10 (0.70–1.75) 0.6878
All Healthy TT 1357 (58.6) 82 (50.9) 1.00 (reference) 1.00 (reference)
(n = 2477) TC /CC 959 (41.4) 79 (49.1) 1.46 (1.05–2.02) * 0.0234 1.40 (1.01–1.95) * 0.0424
Men TT 887 (59.9) 67 (54.9) 1.00 (reference) 1.00 (reference)
TC/ CC 594 (40.1) 55 (45.1) 1.27 (0.88–1.85) 0.2082 1.24 (0.85–1.81) 0.2580
Women TT 470 (56.3) 15 (38.5) 1.00 (reference) 1.00 (reference)
TC/ CC 365 (43.7) 24 (61.5) 2.13 (1.09–4.19) * 0.0277 1.99 (1.01–3.93) * 0.0490
Model 1: Adjusted for age and sex. Model 2: Adjusted for age, sex, and body mass index
a CI, confidence interval. b Diabetes was defined as fasting serum glucose ≥126mg/dL or medication. * significant of p < 0.05
Sull et al. BMC Medical Genetics          (2020) 21:160 Page 3 of 6
Table 5 shows the analysis by BMI for men. The rela-
tionship between MC4R and cardiovascular disease was
stronger in men with BMI < 24.75 (OR, 1.40; 95% CI,
1.12–1.74, p = 0.0028) than in subjects with BMI > = 24.75
(p = 0.6461). However, the interaction between BMI and
MC4R (rs17782313) genotype for cardiovascular disease
was not significant (p for interaction = 0.0753).
Discussion
In a cohort of 4259 people, the rs17782313 SNP in the
MC4R gene was related to serum glucose level, as in
previous studies. A meta-analysis of 123,373 individuals
reported that the rs17782313 polymorphism in MC4R
gene has the BMI independent significant association
with risk of type 2 diabetes [7]. A recent study reported
a strong association with MC4R loci for type 2 diabetes
(OR = 1.70) [2]. Another study reported that the
rs17782313 SNP was significantly associated with in-
creased risk of diabetes [3]. A recent study reported that
a Mediterranean dietary pattern could influence the rela-
tionship between MC4R gene rs17782313 polymor-
phisms and the risk of type 2 diabetes [8]. In our study
for healthy subjects, the association of MC4R gene
rs17782313 with diabetes was stronger in women than
in men. A study also reported that the allele C of MC4R
(rs17782313) was associated with a higher risk of type 2
diabetes mellitus in women [15].
The MC4R gene was associated with BMI and is in-
volved in the regulation of insulin secretion [5, 16]. Loos
et al. [5] in a meta-analysis from European subjects re-
ported a significant association between rs17782313 in
the MC4R gene and BMI in adults and children. A study
also demonstrated that genetic variants in MC4R affect
the obesity phenotype in Koreans [6]. In another meta-
analysis, the association of the MC4R gene with insulin
resistance and type 2 diabetes was reported even after
adjustment for BMI [7]. The MC4R gene (rs17782313
and rs17700633) were related to obesity risk and insulin
resistance in two genome-wide association studies [5, 17].
In this study, we found that the MC4R SNP rs17782313
was associated with BMI and weight.
In this study, the rs17782313 SNP in the MC4R gene
was related to cardiovascular disease in men. The associ-
ation was stronger in lean men than in overweight men.
A recent study reported that MC4R gene may contribute
the co-occurrence of coronary artery disease and obesity
[10]. They reported that the MC4R gene SNPs were as-
sociated with coronary artery disease (p < 5 × 10− 8). They
also explained that the mechanisms whereby MC4R
SNPs contribute to obesity can increase the liability to
coronary artery disease. Another study reported that the
MC4R showed higher expression in mesenteric fat
among obese and diabetic rats then compared with lean
rats [18]. In the present study, the mean age in men with
BMI < 24.75 (52.6 years old) was higher than in men with
Table 4 Odds ratios (OR) of the polymorphic rs17782313 MC4R genotypes for cardiovascular disease in the population (n = 4259)
Subjects Normal Cardiovascular Disease
Model 1 Model 2
Genotype N (%) N (%) OR (95% CIa) P-value OR (95% CI) P-value
All TT 1439 (58.1) 989 (55.5) 1.00 (reference) 1.00 (reference)
TC /CC 1038 (41.9) 793 (44.5) 1.13 (1.00–1.28) 0.0599 1.11 (0.98–1.26) 0.1174
Men TT 954 (59.5) 710 (54.9) 1.00 (reference) 1.00 (reference)
TC/ CC 649 (40.5) 583 (45.1) 1.22 (1.05–1.42)* 0.0096 1.21 (1.04–1.41)* 0.0144
Women TT 485 (55.5) 279 (57.1) 1.00 (reference) 1.00 (reference)
TC/ CC 389 (44.5) 210 (42.9) 0.94 (0.75–1.19) 0.5990 0.89 (0.71–1.13) 0.3474
Model 1: Adjusted for age and sex
Model 2: Adjusted for age, sex, and body mass index
* significant of p < 0.05
a CI, confidence interval
Table 5 Odds ratios (OR) of polymorphic rs17782313 MC4R genotypes for cardiovascular disease in Korean men (n = 2896)
Normal Cardiovascular Disease
Subjects Genotype N (%) N (%) ORa (95% CIb) P-value
BMI < 24.75 TT 516 (61.4) 325 (53.4) 1.00 (reference)
TC/ CC 325 (38.6) 284 (46.6) 1.40 (1.12–1.74)* 0.0028
BMI > =24.75 TT 438 (57.5) 385 (56.3) 1.00 (reference)
TC/ CC 324 (42.5) 299 (43.7) 1.05 (0.85–1.30) 0.6461
* significant of p < 0.05
P for the interaction between obesity (BMI > = 24.75) and MC4R (rs17782313) =0.0753
a Adjusted for age and BMI b CI, confidence interval
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BMI > = 24.75 (51.3 years old) (p = 0.0012). The CVD
patients in men with BMI < 24.75 (42.0%) was smaller
than in men with BMI > = 24.75 (47.3%) (p = 0.0046)
(Data not shown).
MC4R is localized to chromosome 18q21.3 [19], is
highly expressed in the hypothalamus, and is related to
appetite and energy control [20]. In mice research, the
MC4R gene is associated with hyperinsulinemia before
the onset of extreme obesity [21]. Lipocalin-2 crosses
the blood brain barrier and binds to MC4R in the
paraventricular and ventromedial neurons of the hypo-
thalamus. A recent loss- and gain-of-junction experiment
in mice reported that osteoblast-derived lipocalin-2 main-
tains glucose homeostasis [22]. Another recent study re-
ported that the MC4R gene SNPs influence the body fat
content and distribution, as well as relative increase in
postprandial carbohydrate utilization [23].
This study has some limitations that need to be
discussed. There were the differences in the baseline
characteristics including smoking rate, cardiovascular
disease, and diabetes prevalence by gender. When we
assessed the distribution of the MC4R alleles by gender,
the genotype frequency of MC4R gene was similar be-
tween men and women (Data not shown). Another limi-
tation is that this study subjects included many CVD
patients because the CVD cases were obtained from the
KCPS2 dataset (n = 156,701) for the case control study
design [13]. Therefore, we analyzed the association be-
tween diabetes and MC4R gene in the healthy subjects
who did not have the cardiovascular disease.
Conclusion
Asian people may have genetic backgrounds different from
those of Western individuals [24]. However, this Korean co-
hort showed that the rs17782313 SNP in the MC4R gene is
related to diabetes and obesity. The SNP was also associ-
ated with cardiovascular disease in lean men.
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